Descriptive survival outcomes of fruquintinib-based PD-1 inhibitor strategies in advanced colorectal cancer reported as pMMR/MSS: a reconstructed-data analysis of prospective studies

Cancer Treatment and Research Communications · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles